NCT01096056
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Seville, Spain
Clinical trial condition
Influenza
Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.
1,207 public trials
47 recruiting studies
Influenza trial results
NCT01196026
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Rotterdam, Netherlands
- GSK Investigational Site Karlskrona, Sweden
- GSK Investigational Site Malmö, Sweden
- GSK Investigational Site Örebro, Sweden
Completed
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
NCT00980005
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Benton, Arkansas, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Paramount, California, United States
Completed
Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children
NCT01196988
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site Boca Raton, Florida, United States
- GSK Investigational Site Wichita, Kansas, United States
- GSK Investigational Site Wichita, Kansas, United States
NCT01416571
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Mesa, Arizona, United States
NCT00992784
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Güglingen, Baden-Wurttemberg, Germany
- GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Rudersberg, Baden-Wurttemberg, Germany
- GSK Investigational Site Weinheim, Baden-Wurttemberg, Germany
Completed
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
NCT00771615
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Anaheim, California, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Stockbridge, Georgia, United States
NCT00985790
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Ecatepec de Morelos, State of Mexico, Mexico
- GSK Investigational Site Mexico City, Mexico
NCT00920374
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Dresden, Saxony, Germany
- GSK Investigational Site Dresden, Saxony, Germany
- GSK Investigational Site Dresden, Saxony, Germany
- GSK Investigational Site Dresden, Saxony, Germany
NCT01196975
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Mesa, Arizona, United States
- GSK Investigational Site Wichita, Kansas, United States
- GSK Investigational Site Elkridge, Maryland, United States
- GSK Investigational Site Endwell, New York, United States